CE: Advanced Melanoma: A Pharmacist’s Guide to Treatment and Patient Management for New and Emerging Drug Therapies

Pharmacy Practice in Focus: OncologyAugust 2020
Volume 2
Issue 4

This activity is supported by an educational grant from Merck Sharp & Dohme Corp..

This activity is supported by an educational grant from Merck Sharp & Dohme Corp..


At the completion of this activity, the participant will be able to:

  • Explain how genetic mutations and biomarkers influence therapy selection for the treatment of cutaneous melanoma
  • Identify appropriate adjuvant therapy for the treatment of a patient with cutaneous melanoma based on patient- and disease-specific factors
  • Examine guideline recommendations to appropriately place targeted therapies in a patient’s treatment algorithm for advanced melanoma
  • Identify strategies that pharmacists can employ to overcome challenges commonly seen in the management of patients with advanced melanoma


Heather Armbruster, PharmD, BCOP

Specialty Practice Pharmacist, Melanoma

The Ohio State University , James Comprehensive Cancer Center, Columbus, Ohio

TARGET AUDIENCE: Oncology, health-system, and specialty pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: August 14, 2020

EXPIRATION DATE: February 14, 2021


FEE: This lesson is offered for free at www.pharmacytimes.org.

Related Videos
Pharmacist preparing high-risk chemotherapy
Image Credit: © jarun011 - stock.adobe.com
MP Studio - stock.adobe.com
Image credit: David A Litman | stock.adobe.com
Credit: AkuAku - stock.adobe.com
Portrait of young female pharmacist holding medication while using computer at pharmacy counter | Image Credit: Dragana Gordic - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.